Drugs / Bivalent rLukS-PV / rAT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01011335 | Nov 2009 → Mar 2011 | staphylococcus aureus infection | Henry M. Jackson Foundation for the Advancement of Military Medicine | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bivalent rLukS-PV / rAT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01011335 ↗ |